PRENATAL DIAGNOSTICS PIONEER JOINS CEDARS-SINAI MEDICAL CENTER
Cedars-Sinai Medical Center's Department of Obstetrics and Gynecology has served
as the Los Angeles area's training and quality assurance center since the "The
First Trimester Maternal Serum Biochemistry and Fetal Ultrasound Nuchal
Translucency Screening Study," or BUN study, was started last year. Recently,
Rosalinde Snijders, Ph.D., a pioneer in first-trimester prenatal studies and a
consultant to the National Institutes of Health in the development of BUN study,
has became a research scholar in the Department of Obstetrics and Gynecology at
Cedars-Sinai.
MITRAL VALVE REPAIR GETS DENTIST ON THE ROAD TO RECOVERY
Mitral valve prolapse is a very common cardiac diagnosis, affecting an estimated
5 percent to 20 percent of the population. Also known as "click-murmur
syndrome," the condition results when the mitral valve "prolapses" or collapses
backward. Although usually a benign condition, there is sometimes a leak that
progressively worsens. Since 1996, physicians at Cedars-Sinai have treated more
than 100 patients annually with severe mitral regurgitation, and approximately
80 percent will undergo valve repair, a successful alternative to more
conventional valve replacement.
VENTRICULAR ASSIST SURGERY ENABLES A DEFECTIVE HEART TO REST WHILE AWAITING A
TRANSPLANT
A Cedars-Sinai heart transplant surgeon specializes in implanting mechanisms
(Ventricular assist device surgery) that allow a defective heart to rest while
awaiting a transplant. Ventricular assist device surgery as a bridge to heart
transplantation or a bridge to recovery is the forefront of what's happening in
heart failure cardiology and heart failure surgery today. Heart transplant
surgeon Kathy Elizabeth Magliato, M.D., one of only a handful of women who do
heart transplants, specializes in implanting mechanisms that allow a defective
heart to rest while awaiting a transplant.
CEDARS-SINAI COMPREHENSIVE CANCER CENTER ADDS NEW DIMENSION IN RADIATION
TREATMENT
A next-generation radiation therapy system that allows physicians to "shape"
radiation treatments three-dimensionally to match irregularly contoured tumors
is now available at Cedars-Sinai Medical Center's Comprehensive Cancer Center.
The RadionicsR ConforMAX Mini-Multileaf Collimator (mMLC(tm)), approved for use
by the Food and Drug Administration earlier this year, is a device that attaches
to a linear accelerator to focus and direct the radiation beam generated by the
accelerator.
For media information and to pursue any of these story ideas, please call 1-800-396-1002 or e-mail sandy@vancommunications.com .